Breast Cancer Trial, Recruiting NCT07003841 Sponsor: SKIA Inc. Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07003841
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 19 to 80 years who have been diagnosed with breast cancer confirmed by biopsy.
  • People who have had all three types of scans: MRI, CT, and ultrasound.
  • People diagnosed with breast cancer who are planned to have breast-conserving surgery (surgery that removes the tumour but keeps most of the breast), have not had chemotherapy before surgery, and whose cancer has not spread to other parts of the body.
  • People whose tumour measures between 5mm and 30mm as seen on ultrasound.
  • People whose biopsy results show a type of cancer called invasive carcinoma.
  • People who have only one tumour in the breast.
  • People who have been fully informed about the trial, understand what it involves, and have chosen to take part by signing a consent form.

Who may not be able to join:

  • People for whom MRI, CT, or ultrasound scans are not medically safe or permitted.
  • People whose tumour cannot be seen on a CT scan.
  • People who are pregnant or currently breastfeeding.
  • People who are biologically male.
  • People who have already received chemotherapy before surgery, or whose breast cancer has spread to other parts of the body.
  • People whose biopsy results show a specific type called invasive lobular carcinoma.
  • People the trial doctor considers unsuitable for the study for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +821048856620

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
SKIA Inc.
Registry
ClinicalTrials.gov
Start date
19 November 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Negative margin resection rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov